m6A阅读蛋白YTHDF2调控ACSL4介导糖尿病角质形成细胞铁死亡及其在伤口愈合中的作用机制研究
批准号:
82100874
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
吴良燕
依托单位:
学科分类:
糖尿病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
吴良燕
中文摘要
糖尿病皮肤角质形成细胞减少,皮肤变薄,伤口难愈,机制有待研究。我们发现糖尿病角质形成细胞存在铁死亡:其铁死亡关键蛋白ACSL4、及脂过氧化增加,同时伴有m6A阅读蛋白YTHDF2减少。YTHDF2功能是促进m6A修饰的mRNA降解,那么糖尿病状态下YTHDF2是否能调控ACSL4的表达,导致角质形成细胞铁死亡,目前尚不清楚?且我们已证明YTHDF2能结合m6A修饰的ACSL4 mRNA。因此我们假设糖尿病状态下,角质形成细胞下调的YTHDF2,使ACSL4表达增加,引起细胞发生铁死亡,导致皮肤易损难愈,而过表达YTHDF2或铁死亡抑制剂均可以挽救细胞铁死亡促进伤口愈合。故本项目拟采用慢病毒过表达及敲低YTHDF2、RIP-qPCR等方法来阐明YTHDF2调控m6A修饰的ACSL4 介导糖尿病角质形成细胞铁死亡及其在糖尿病伤口愈合中的作用,为糖尿病皮肤伤口治疗的提供新思路。
英文摘要
The diabetic keratinocytes were fewer and thickness of skin was thinner,which leads to poor wound healing in diabetes. The underlying mechanisms remain largely unknown. We provided evidence showing both the acyl-CoA synthetase long-chain family member 4(ACSL4)(a key regulator of ferroptosis)and lipid peroxidation products were increased, while m6A reader YTHDF2 was reduced in diabetic keratinocytes. And YTHDF2 was reported to regulate degradation of m6A-modifed mRNAs. However, whether YTHDF2 can mediate the stability of ACSL4 mRNA is still unknown? We found that ACSL4 mRNA was modified by m6A and bound by YTHDF2. So we hypothesize that decreased YTHDF2 can increase the expression of ACSL4, thus causing ferroptosis of keratinocytes and impairing wound healing during diabetic condition. Specific overexpression of YTHDF2 and application of ferroptosis inhibitors could promote wound healing through inhibiting ferroptosis of keratinocytes. Therefore, Molecular and cellular techniques, including lentiviral vector-mediated knockdown or overexpression and RIP-qPCR will be used to elucidate the mechanism that YTHDF2-regulated m6A modification of ACSL4 mediates ferroptosis in diabetic keratinocytes, so as to provide novel therapeutic targets and strategies for improving diabetic wound healing.
目前糖尿病发病率高,其并发症涉及全身各器官。伤口愈合障碍是糖尿病最常见的并发症之一,危害性大,如何促进糖尿病伤口愈合是临床上的热点和难点,且机制未明,皮肤角质形成细胞功能紊乱为主要原因,机制有待研究。糖尿病患者肝损害也较为常见,机制未明确。而铁死亡作为一种新兴的死亡机制,在代谢性疾病如糖尿病及其并发症发挥了重要作用,故围绕铁死亡及关键启动因子ACSL4在糖尿病伤口愈合、糖尿病肝损害中的作用及机制展开了研究。项目主要研究内容包括:①m6A阅读蛋白YTHDF2调控ACSL4介导角质形成细胞铁死亡在糖尿病伤口愈合中的作用及机制研究;②多肽水凝胶缓释MMP-9 siRNA在糖尿病伤口愈合中的作用研究;③组蛋白赖氨酸巴豆酰化通过自噬介导ACSL4诱导的角质形成细胞铁死亡调节糖尿病伤口愈合的机制;④自噬调控ACSL4介导铁死亡导致糖尿病肝损伤作用及机制研究。重要结果及关键数据:①糖尿病状态下ACSL4表达增加介导角质形成细胞铁死亡增加,铁死亡抑制剂Ferrostatin-1可促进糖尿病大鼠皮肤伤口愈合。机制上,糖尿病状态下YTHDF2下调,调控m6A修饰的ACSL4表达,siYTHDF2通过ACSL4调控铁死亡影响伤口愈合。②利用G0-C14作为MMP-9siRNA的基因载体,合成多肽凝胶包载并缓释G0-C14/siRNA,安全有效的抑制角质形成细胞 MMP-9的表达,促进糖尿病伤口愈合。③糖尿病角质形成细胞的总巴豆酰化及H3K27cr显著增加,H3K27cr通过调节SQSTM1抑制糖尿病角质形成细胞自噬,调控ACSL4降解,介导铁死亡。④糖尿病大鼠肝细胞及棕榈酸(PA)处理的LO2细胞ACSL4上调介导铁死亡和自噬抑制,铁死亡抑制剂能减轻PA诱导的LO2细胞死亡。机制上,ACSL4主要通过自噬-溶酶体途径降解,自噬通过介导ACSL4的降解来调节铁死亡介导糖尿病肝损伤。项目作者为第一或者通讯作者以相关内容拟发表SCI论文4篇,已发表 2篇,单篇最高IF为15.1,申请发明专利1项。科学意义:项目研究初步阐明ACSL4调控的铁死亡、自噬、m6A修饰、巴豆酰化在糖尿病伤口愈合、肝损害的调控作用及机制,为糖尿病伤口愈合、肝损害等并发症等提供了新的靶点和策略。
国内基金
海外基金